165 related articles for article (PubMed ID: 2946331)
1. Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia.
Griffin JD; Davis R; Nelson DA; Davey FR; Mayer RJ; Schiffer C; McIntyre OR; Bloomfield CD
Blood; 1986 Dec; 68(6):1232-41. PubMed ID: 2946331
[TBL] [Abstract][Full Text] [Related]
2. Correlation of surface marker expression with morphologically and immunologically defined subclasses of acute myeloid leukaemias.
Drexler HG; Menon M; Klein M; Bhoopalam N; Messmore HL; Minowada J
Clin Exp Immunol; 1986 Aug; 65(2):363-72. PubMed ID: 3466728
[TBL] [Abstract][Full Text] [Related]
3. Reactivity patterns of monoclonal antibodies positive on myelomonocytic leukemia cells as defined by esterase isoenzyme analysis.
Drexler HG; Menon M; Gaedicke G; Minowada J
Cancer Immunol Immunother; 1986; 21(3):188-92. PubMed ID: 3457629
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of surface marker expression on blasts of patients with de novo acute myeloblastic leukemia.
Schwarzinger I; Valent P; Köller U; Marosi C; Schneider B; Haas O; Knapp W; Lechner K; Bettelheim P
J Clin Oncol; 1990 Mar; 8(3):423-30. PubMed ID: 2307987
[TBL] [Abstract][Full Text] [Related]
5. Acute myeloid leukemia, FAB M-1 microgranular variant: a multiparameter study.
Nguyen D; Brynes RK; Macaulay L; Kaplan B; Pinter-Brown LC
Hematol Pathol; 1989; 3(1):11-22. PubMed ID: 2545666
[TBL] [Abstract][Full Text] [Related]
6. Expression of myeloid differentiation antigens on normal and malignant myeloid cells.
Griffin JD; Ritz J; Nadler LM; Schlossman SF
J Clin Invest; 1981 Oct; 68(4):932-41. PubMed ID: 6945311
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotyping of acute myeloid leukemia using monoclonal antibodies and the alkaline phosphatase-antialkaline phosphatase technique.
Hanson CA; Gajl-Peczalska KJ; Parkin JL; Brunning RD
Blood; 1987 Jul; 70(1):83-9. PubMed ID: 3297208
[TBL] [Abstract][Full Text] [Related]
8. Immunologic classification of leukemia and lymphoma.
Foon KA; Todd RF
Blood; 1986 Jul; 68(1):1-31. PubMed ID: 2941082
[TBL] [Abstract][Full Text] [Related]
9. Differentiation phenotypes on cells of acute myeloid leukemia studied by My7, My9, My4, Mo1 and Ja monoclonal antibodies.
Büchi G; Girotto M; Baldini G; Grosso E; Termine G; Gario S; Autino R; Zappalà C; Ganio D
Pathologica; 1987; 79(1064):699-704. PubMed ID: 3503228
[No Abstract] [Full Text] [Related]
10. Undifferentiated leukemia of infancy with t(11:17) chromosomal rearrangement. Coexpressing myeloid and B cell restricted antigens.
Umiel T; Nadler LM; Cohen IJ; Levine H; Stark B; Mammon Z; Dzaldetti M; Rechavi G; Simoni F; Katzir N
Cancer; 1987 Mar; 59(6):1143-9. PubMed ID: 3102033
[TBL] [Abstract][Full Text] [Related]
11. Acute mixed lineage leukemia: clinicopathologic correlations and prognostic significance.
Mirro J; Zipf TF; Pui CH; Kitchingman G; Williams D; Melvin S; Murphy SB; Stass S
Blood; 1985 Nov; 66(5):1115-23. PubMed ID: 3931724
[TBL] [Abstract][Full Text] [Related]
12. Reactivity pattern of 'myeloid monoclonal antibodies' with emphasis on MCS-2.
Drexler HG; Sagawa K; Menon M; Minowada J
Leuk Res; 1986; 10(1):17-23. PubMed ID: 3456072
[TBL] [Abstract][Full Text] [Related]
13. Surface marker analysis of acute myeloblastic leukemia: identification of differentiation-associated phenotypes.
Griffin JD; Mayer RJ; Weinstein HJ; Rosenthal DS; Coral FS; Beveridge RP; Schlossman SF
Blood; 1983 Sep; 62(3):557-63. PubMed ID: 6309279
[TBL] [Abstract][Full Text] [Related]
14. Expression of monocytic and T-lymphocytic phenotype in a variant form of acute promyelocytic leukaemia (M3).
Sato T; Abe R; Kawaguchi M; Uchida T; Kariyone S
Scand J Haematol; 1986 Aug; 37(2):151-3. PubMed ID: 3489982
[TBL] [Abstract][Full Text] [Related]
15. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia].
Imamura N; Kuramoto A; Kawaguchi Y; Tanaka R
Rinsho Ketsueki; 1989 Jan; 30(1):11-21. PubMed ID: 2541276
[TBL] [Abstract][Full Text] [Related]
16. Acute myeloid leukemia with T-lymphoid features: a distinct biologic and clinical entity.
Cross AH; Goorha RM; Nuss R; Behm FG; Murphy SB; Kalwinsky DK; Raimondi S; Kitchingman GR; Mirro J
Blood; 1988 Aug; 72(2):579-87. PubMed ID: 3261183
[TBL] [Abstract][Full Text] [Related]
17. High Ia (HLA-DR) and low CD11b (Mo1) expression may predict early conversion to leukemia in myelodysplastic syndromes.
Mittelman M; Karcher DS; Kammerman LA; Lessin LS
Am J Hematol; 1993 Jul; 43(3):165-71. PubMed ID: 8352230
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and molecular heterogeneity in Philadelphia chromosome-positive acute leukemia.
Hirsch-Ginsberg C; Childs C; Chang KS; Beran M; Cork A; Reuben J; Freireich EJ; Chang LC; Bollum FJ; Trujillo J
Blood; 1988 Jan; 71(1):186-95. PubMed ID: 3334895
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies in myeloid diseases: prognostic use in acute myeloid leukaemia.
Kristensen JS; Hokland P
Leuk Res; 1991; 15(8):693-700. PubMed ID: 1895750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
